Aouissi Hani Amir, Ababsa Mostefa, Gaagai Aissam
Scientific and Technical Research Center On Arid Regions (CRSTRA), 07000 Biskra, Algeria.
Department of Biology, Faculty of Sciences, Badji-Mokhtar Annaba University, 23000 Annaba, Algeria.
Bull Natl Res Cent. 2021;45(1):94. doi: 10.1186/s42269-021-00550-w. Epub 2021 May 20.
As of April 23, 2021, more than 145 million cases and almost 3.07 million related deaths were noted because of the coronavirus (Covid-19) Pandemic. Considering the low rate vaccination, the alternative that divided opinions for a long time is an old medicine called hydroxychloroquine.
The aim of this review was to synthesize the different highlights of the most important studies published since the beginning of the epidemic crisis. After a precise study of the available bibliography dealing with this subject and the addition of an adapted example, which is the current situation of Algeria, the results showed the effectiveness of the Algerian method as well as the impact that this treatment had.
We concluded that in brief, given the inexistence of a better solution, we ultimately recommend that patients with severe COVID-19 to be treated for the moment with Hydroxychloroquine combined with Azithromycin in view of its effectiveness, while waiting for another solution.
截至2021年4月23日，由于冠状病毒（新冠病毒-19）大流行，已记录到超过1.45亿例病例和近307万例相关死亡。考虑到疫苗接种率较低，一种长期以来存在争议的替代方案是一种名为羟氯喹的老药。
本综述的目的是综合自疫情危机开始以来发表的最重要研究的不同要点。在对有关该主题的现有文献进行精确研究并添加一个合适的例子（即阿尔及利亚的现状）后，结果显示了阿尔及利亚方法的有效性以及这种治疗所产生的影响。
我们简而言之得出结论，鉴于不存在更好的解决方案，鉴于其有效性，我们最终建议目前对重症新冠病毒-19患者采用羟氯喹联合阿奇霉素进行治疗，同时等待其他解决方案。
